You are here

Fish Technology to Localize a Prostate Cancer Gene

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 CA67501-01,
Agency Tracking Number: 29221
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1995
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
100 Beaver Street
Waltham, MA 02154
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Katherine Call
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract

Although prostate cancer is the most common malignancy among males in the U.S, little is known abougenes involved in prostate carcinogenesis. Cytogenetic and restriction fragment polymorphism data haof 10q in as many as 30% of prostate cancers. In a collaborative effort with a prostate cancer laborEdward Gelmann (Georgetown Univ.), we have shown that the microsatellite marker D10S187 in 10q25 exhheterozygosity (LOH) in approximately one third of primary prostate tumors. Thus, our long-term goalgene(s) in 10q24-25 involved in prostate cancer. Identification and cloning of a prostate cancer suscontribute to our understanding of prostate carcinogenesis. Our primary aim in Phase I is to assessfluorescence in situ hybridization (FISH) technology to detect and finely map 10q deletion events inThe degree of resolution with FISH will be greater than can be obtained with the limited number of 1markers suitable for LOH analysis. Our secondary aims involve increasing the number of YAC and cosmiinformation in the 10q25 region in which the prostate tumor susceptibility gene resides.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government